ArticleViruses2022
Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus.
Jun Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it
ArticleViruses2022
Jun Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.